Targeted Alpha Therapy Using Astatine (At-211) Against Differentiated Thyroid Cancer
Clinical trial NCT05275946 · COMPLETED
Trial details
- NCT number
- NCT05275946
- Sponsor
- Osaka University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-20
- Primary completion
- 2024-12-31
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.